Christine J. Guico-Pabia

Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder

M. Fava, S. Montgomery, S. K. Padmanabhan, 2009, International clinical psychopharmacology.